MRNA

Moderna, Inc.

Biological Products, (No Diagnostic Substances)NasdaqLarge accelerated filer

Total Trades

487

Buys

0

Sells

298

Largest Trade

N/A

Insiders

11

Institutional Funds

576

Inst. Value

$1M+

Activist Filings

17

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Klinger Shannon ThymeChief Legal OfficerSELL$15K–$50K183$144.50May 30, 2024
Klinger Shannon ThymeChief Legal OfficerEXERCISEN/A328May 30, 2024
Hoge StephenPresidentEXERCISEN/A610May 30, 2024
Hoge StephenPresidentSELL$15K–$50K341$144.50May 30, 2024
Mock James MCFOEXERCISEN/A1KMay 29, 2024
Mock James MCFOSELL$100K–$500K648$162.47May 29, 2024
Klinger Shannon ThymeChief Legal OfficerEXERCISEN/A3KMay 29, 2024
Klinger Shannon ThymeChief Legal OfficerSELL$100K–$500K1K$162.47May 29, 2024
AFEYAN NOUBARDirectorSELL$1M+15K$157.57May 24, 2024
AFEYAN NOUBARDirectorSELL$1M+15K$110.92May 3, 2024
AFEYAN NOUBARDirectorSELL$1M+15K$108.32Apr 26, 2024
AFEYAN NOUBARDirectorSELL$1M+15K$103.38Apr 19, 2024
Hoge StephenPresidentSELL$1M+15K$105.02Apr 16, 2024
AFEYAN NOUBARDirectorSELL$1M+15K$107.12Apr 12, 2024
Mock James MCFOEXERCISEN/A1KApr 9, 2024
Mock James MCFOSELL$50K–$100K705$101.93Apr 9, 2024
AFEYAN NOUBARDirectorSELL$1M+15K$101.68Apr 5, 2024
AFEYAN NOUBARDirectorSELL$1M+15K$109.06Mar 29, 2024
AFEYAN NOUBARDirectorSELL$1M+15K$102.39Mar 22, 2024
Mock James MCFOEXERCISEN/A1KMar 1, 2024
Mock James MCFOSELL$50K–$100K647$94.57Mar 1, 2024
Klinger Shannon ThymeChief Legal OfficerEXERCISEN/A1KMar 1, 2024
Klinger Shannon ThymeChief Legal OfficerSELL$50K–$100K670$94.57Mar 1, 2024
Hoge StephenPresidentEXERCISEN/A5KMar 1, 2024
Hoge StephenPresidentSELL$100K–$500K2K$94.57Mar 1, 2024
Hoge StephenPresidentSELL$1M+15K$100.00Feb 23, 2024
Hoge StephenPresidentGRANTN/A23KFeb 16, 2024
Hoge StephenPresidentSELL$500K+11K$88.88Feb 16, 2024
Bancel StephaneCEOSELL$1M+26K$88.88Feb 16, 2024
Bancel StephaneCEOGRANTN/A57KFeb 16, 2024
Hoge StephenPresidentEXERCISEN/A522Feb 13, 2024
Hoge StephenPresidentSELL$15K–$50K304$86.23Feb 13, 2024
Hoge StephenPresidentSELL$1M+15K$103.90Jan 17, 2024
Hoge StephenPresidentSELL$1M+45K$100.01Dec 28, 2023
Hoge StephenPresidentSELL$50K–$100K1K$79.81Nov 30, 2023
Hoge StephenPresidentEXERCISEN/A2KNov 30, 2023
Hoge StephenPresidentSELL$15K–$50K263$68.76Nov 13, 2023
Hoge StephenPresidentEXERCISEN/A522Nov 13, 2023
AFEYAN NOUBARDirectorSELL$500K+10K$76.00Nov 3, 2023
AFEYAN NOUBARDirectorSELL$500K+10K$76.99Oct 27, 2023
AFEYAN NOUBARDirectorSELL$1M+15K$103.30Oct 13, 2023
Mock James MCFOEXERCISEN/A6KOct 10, 2023
Mock James MCFOSELL$100K–$500K3K$102.50Oct 10, 2023
AFEYAN NOUBARDirectorSELL$1M+15K$102.72Oct 6, 2023
AFEYAN NOUBARDirectorSELL$500K+10K$98.96Sep 29, 2023
AFEYAN NOUBARDirectorSELL$1M+15K$104.74Sep 22, 2023
Hoge StephenPresidentSELL$1M+15K$112.99Sep 18, 2023
AFEYAN NOUBARDirectorSELL$1M+15K$109.70Sep 15, 2023
Klinger Shannon ThymeChief Legal OfficerSELL$50K–$100K557$107.22Sep 11, 2023
Klinger Shannon ThymeChief Legal OfficerEXERCISEN/A1KSep 11, 2023
🔓Seeing ranges? Sign in for exact trade values — free forever

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

BAILLIE GIFFORD & CO

SC 13G/A · Feb 9, 2026

5.3%

20.6M shares

FMR LLC

SC 13G/A · Feb 6, 2026

10.6%

41.3M shares

FMR LLC

SC 13G · Feb 5, 2026

7.2%

28.0M shares

FMR LLC

SC 13G/A · Nov 5, 2025

3.2%

12.3M shares

FMR LLC

SC 13G · May 12, 2025

5.5%

21.1M shares

BAILLIE GIFFORD & CO

SC 13G/A · Apr 30, 2025

6.5%

24.9M shares

BAILLIE GIFFORD & CO

SC 13G/A · Feb 12, 2025

10.1%

38.9M shares

The Vanguard Group - 23-1945930

SC 13G/A · Apr 10, 2024

10.2%

39.0M shares

The Vanguard Group - 23-1945930

SC 13G/A · Feb 13, 2024

8.9%

33.9M shares

BlackRock, Inc.

SC 13G/A · Jan 29, 2024

6.6%

25.3M shares

12.0%

45.7M shares

Stéphane Bancel

SC 13G/A · Feb 10, 2023

7.4%

29.2M shares

BlackRock, Inc.

SC 13G/A · Jan 31, 2023

6.8%

26.1M shares

11.7%

44.8M shares

Flagship VentureLabs IV, LLC

SC 13G/A · Feb 14, 2022

2.8%

11.5M shares

Stéphane Bancel

SC 13G/A · Feb 14, 2022

7.6%

31.5M shares

11.3%

45.8M shares

View on Google Finance →